Clinical Trials
84 trialsSURVIMON
N.N. Petrov National Medical Research Center of Oncology
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
National Institutes of Health Clinical Center (CC)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
SHERLOCK
University Health Network, Toronto
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Eastern Cooperative Oncology Group
iCaRe2
University of Nebraska
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
DP-04
AstraZeneca
ELEPHAS-02
Elephas
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CER
Cancer Support Community, Research and Training Institute, Philadelphia
TraveraRTGx
Travera Inc
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
COSMIC
Wake Forest University Health Sciences
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Ohio State University
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma
EVpredict
Centre Georges Francois Leclerc
SCORE
Natera, Inc.
ELEPHAS-05
Elephas
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Pharmassist Ltd
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Mayo Clinic
LIBERATE
University Health Network, Toronto
NEUTROFLOW
OncoHost Ltd.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
PROPHETIC
OncoHost Ltd.
SBRT
Mayo Clinic
ORACLE
Guardant Health, Inc.
Pan-tumor MRD Study
Paradigm Health
PARTNER
Azienda Ospedaliera di Padova
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
PREFER
Labcorp Corporation of America Holdings, Inc
TasteSPICIER
University Medical Center Groningen
MOM
Inova Health Care Services
BEGIN
BostonGene
MOHCCN-O
University Health Network, Toronto
GENIUS
University Health Network, Toronto
ROOT
Taproot Health
OCTANE
University Health Network, Toronto
CANSI
Turku University Hospital
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SPICE
University of Cologne
BESPOKE Study of ctDNA Guided Immunotherapy
Natera, Inc.
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
National Institutes of Health Clinical Center (CC)
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Bristol-Myers Squibb